Hologic HOLX is set to release first-quarter fiscal 2025 results on Feb. 5 after the closing bell. Stay up-to-date with all ...

Hologic Below 50-Day SMA Image Source: Zacks Investment Research Before taking the stage at the Annual J.P. Morgan Healthcare Conference yesterday, Hologic provided a glimpse into its first ...

Hologic (HOLX) concluded the recent trading session at $71.77, signifying a -1.35% move from its prior day's close. In the first quarter of fiscal 2025, HOLX is expected to have benefited from the ...

Hologic is down approximately 20% from recent highs and continues to grow organically and via a series of 'bolt-on' ...

Hologic (HOLX) closed at $71.19 in the latest trading session, marking a +1.17% move from the prior day. This change outpaced the S&P 500's 0.61% gain on the day. Meanwhile, the Dow gained 0.3% ...

The gantry side of the business is preparing for the upcoming launch of its next-generation gantry, which aims to improve workflows, patient experience and image quality. Alongside this ...

They consist of a plastic component intended to dissolve into patients’ bodies and a permanent metal component. Hologic acquired Biozorb in 2018 with its purchase of Focal Therapeutics. Since 2015, ...

The global liquid biopsy tube market exhibits promising growth prospects, driven by advancements in cancer diagnostics and the increasing prevalence of ...